Dr. Patrice Hugo has more than 30 years of senior scientific leadership experience in laboratory operations, drug target and biomarker discovery & assay validation applied to drug development and diagnostics. He currently leads the scientific strategy and medical affairs and responsible for expanding laboratory testing to support clinical trials across therapeutic areas such as Oncology, Neurology (e.g. dementia) for the global Central Laboratories and specialty testing services including routine safety, Companion Diagnostics, Pathology, Genomics/ Genetics, Molecular, Vaccine, Flow Cytometry, Proteomics, Translational Science, Antibody library drug discovery, Bioanalytical PK, immunogenicity and ADME. In his prior appointment, Dr. Hugo was an Associate Vice President and Chief Clinical Trial Scientist at LabCorp/Covance. Dr. Hugo holds a Ph.D. in Experimental Medicine & Immunology at McGill University and held post-doctoral positions at the WEHI, Australia, and Howard Hughes Medical Institute, USA. He has published more than 75 scientific publications in internationally renowned journals and has been invited to speak at over 200 conferences.